Literatura académica sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy"
Chung, Sun-Ku y Seo-Young Lee. "Advances in Gene Therapy Techniques to Treat LRRK2 Gene Mutation". Biomolecules 12, n.º 12 (5 de diciembre de 2022): 1814. http://dx.doi.org/10.3390/biom12121814.
Texto completoRahman, Mujeeb ur, Muhammad Bilal, Junaid Ali Shah, Ajeet Kaushik, Pierre-Louis Teissedre y Małgorzata Kujawska. "CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease". Pharmaceutics 14, n.º 6 (13 de junio de 2022): 1252. http://dx.doi.org/10.3390/pharmaceutics14061252.
Texto completoDe Plano, Laura M., Giovanna Calabrese, Sabrina Conoci, Salvatore P. P. Guglielmino, Salvatore Oddo y Antonella Caccamo. "Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders". International Journal of Molecular Sciences 23, n.º 15 (5 de agosto de 2022): 8714. http://dx.doi.org/10.3390/ijms23158714.
Texto completoKatzmann, Julius L., Arjen J. Cupido y Ulrich Laufs. "Gene Therapy Targeting PCSK9". Metabolites 12, n.º 1 (12 de enero de 2022): 70. http://dx.doi.org/10.3390/metabo12010070.
Texto completoTang, Xuanting. "CRISPR/Cas9-based genome engineering in HIV gene therapy". E3S Web of Conferences 233 (2021): 02004. http://dx.doi.org/10.1051/e3sconf/202123302004.
Texto completoS., Manasa M. "CRISPR-Cas9 gene editing technology in human gene therapy: the new realm of medicine". International Journal of Advances in Medicine 9, n.º 4 (24 de marzo de 2022): 513. http://dx.doi.org/10.18203/2349-3933.ijam20220796.
Texto completoPreece, Roland y Christos Georgiadis. "Emerging CRISPR/Cas9 applications for T-cell gene editing". Emerging Topics in Life Sciences 3, n.º 3 (2 de abril de 2019): 261–75. http://dx.doi.org/10.1042/etls20180144.
Texto completoLiu, Wenlou, Chunsheng Yang, Yanqun Liu y Guan Jiang. "CRISPR/Cas9 System and its Research Progress in Gene Therapy". Anti-Cancer Agents in Medicinal Chemistry 19, n.º 16 (23 de enero de 2020): 1912–19. http://dx.doi.org/10.2174/1871520619666191014103711.
Texto completoSalsman, Jayme y Graham Dellaire. "Precision genome editing in the CRISPR era". Biochemistry and Cell Biology 95, n.º 2 (abril de 2017): 187–201. http://dx.doi.org/10.1139/bcb-2016-0137.
Texto completoKanu, Gayathri A., Javad B. M. Parambath, Raed O. Abu Odeh y Ahmed A. Mohamed. "Gold Nanoparticle-Mediated Gene Therapy". Cancers 14, n.º 21 (31 de octubre de 2022): 5366. http://dx.doi.org/10.3390/cancers14215366.
Texto completoTesis sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy"
Giada, Beligni. "Application of the CRISPR-Cas9 genome editing approach for the correction of the p.Gly2019Ser (c.6055G>A) LRRK2 variant in Parkinson Disease". Doctoral thesis, Università di Siena, 2022. https://hdl.handle.net/11365/1220257.
Texto completoPigini, Paolo <1991>. "Neuroblastoma targeted therapy: employment of CRISPR gene-editing to explore relevant markers and potential targets in aggressive tumours". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2019. http://amsdottorato.unibo.it/8752/1/Pigini_Paolo_tesi.pdf.
Texto completoYang, Luhan. "Development of Human Genome Editing Tools for the Study of Genetic Variations and Gene Therapies". Thesis, Harvard University, 2013. http://dissertations.umi.com/gsas.harvard:11117.
Texto completoFine, Eli Jacob. "A toolkit for analysis of gene editing and off-target effects of engineered nucleases". Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/54875.
Texto completoAmaya, Colina Anais Karime. "Towards the Treatment of Human Genetic Liver Disease by AAV-Mediated Genome Editing and Selective Expansion of Repaired Hepatocytes". Thesis, The University of Sydney, 2019. https://hdl.handle.net/2123/21893.
Texto completoFoster, Robert Graham. "Development of a modular in vivo reporter system for CRISPR-mediated genome editing and its therapeutic applications for rare genetic respiratory diseases". Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/33040.
Texto completoHsu, Patrick David. "Development of the CRISPR nuclease Cas9 for high precision mammalian genome engineering". Thesis, Harvard University, 2014. http://nrs.harvard.edu/urn-3:HUL.InstRepos:13068392.
Texto completoMINGOIA, MAURA. "Terapia genica della β Talassemia mediante editing del DNA". Doctoral thesis, Università degli Studi di Cagliari, 2016. http://hdl.handle.net/11584/266632.
Texto completoKennedy, Zachary C. "Optimizing CRISPR/Cas9 for Gene Silencing of SOD1 in Mouse Models of ALS". eScholarship@UMMS, 2019. https://escholarship.umassmed.edu/gsbs_diss/1047.
Texto completoSchneider, Sara Jane. "Delivery of CRISPR/Cas9 RNAs into Blood Cells of Zebrafish: Potential for Genome Editing in Somatic Cells". Thesis, University of North Texas, 2017. https://digital.library.unt.edu/ark:/67531/metadc1011754/.
Texto completoCapítulos de libros sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy"
Hung, Sandy S., Fan Li, Jiang-Hui Wang, Anna E. King, Bang V. Bui, Guei-Sheung Liu y Alex W. Hewitt. "Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina". En Retinal Gene Therapy, 113–33. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7522-8_9.
Texto completoMaría Vaschetto, Luis. "CRISPR/Cas and Gene Therapy: An Overview". En CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and Diseases, 85–89. New York: CRC Press, 2021. http://dx.doi.org/10.1201/9781003088516-5.
Texto completoGouw, Arvin M. "Challenging the Therapy/Enhancement Distinction in CRISPR Gene Editing". En The Palgrave Handbook of Philosophy and Public Policy, 493–508. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-93907-0_38.
Texto completoLópez-Márquez, Arístides, Ainhoa Martínez-Pizarro, Belén Pérez, Eva Richard y Lourdes R. Desviat. "Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells". En Methods in Molecular Biology, 167–84. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2010-6_10.
Texto completoMandal, Shubhjeet y Piyush Kumar Tiwari. "Gene Therapy and Gene Editing for Cancer Therapeutics". En Handbook of Research on Advancements in Cancer Therapeutics, 116–204. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-6530-8.ch004.
Texto completoScherman, Daniel y Jean-Louis Mandel. "GENOME ENGINEERING AND GENOME EDITING USING CRISPR/CAS9–RNA-GUIDED NUCLEASE". En Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology, 115–30. WORLD SCIENTIFIC (EUROPE), 2019. http://dx.doi.org/10.1142/9781786346889_0008.
Texto completoRamirez, Juan C. "Gene Editing and CRISPR Therapeutics: Strategies Taught by Cell and Gene Therapy". En Progress in Molecular Biology and Translational Science, 115–30. Elsevier, 2017. http://dx.doi.org/10.1016/bs.pmbts.2017.08.003.
Texto completoBecerra, Edgardo, Valeria Soto-Ontiveros y Guadalupe García Alcocer. "CRISPR-Cas9-based Strategies for Acute Lymphoblastic Leukemia Therapy". En Leukemia - From Biology to Diagnosis and Treatment [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.106702.
Texto completoRao, J. Venkateshwara, R. Ravindar Naik, S. Venkanna y N. Ramesh Kumar. "Application of 21st Century Genetic Engineering Tools and CRISPR-Cas9 Technologies to Treat Most Advanced Cardiovascular Diseases of Humans". En Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives, 79–103. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815050837122010008.
Texto completoEjaz, Mahnoor, Areena Suhail Khan, Faiza Naseer y Alvina Gul. "Metabolic Syndromes". En Omics Technologies for Clinical Diagnosis and Gene Therapy: Medical Applications in Human Genetics, 242–68. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815079517122010018.
Texto completoActas de conferencias sobre el tema "CRISPR, Gene editing, Parkinson, Gene therapy"
Divita, Gilles, Elodie Czuba, Melanie Guidetti, Audrey Gunenberger, Leslie Tempremant, Veronique Josserand y Neil Desai. "Abstract 1826: CRISPR mediated KRAS mutant gene editing in pancreatic and colorectal cancer therapy". En Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-1826.
Texto completo